These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32205484)

  • 1. HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma.
    Naso JR; Tsuji S; Churg A
    Am J Surg Pathol; 2020 Aug; 44(8):1143-1148. PubMed ID: 32205484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small-cell lung carcinoma with only two stains in most cases.
    Churg A; Naso JR
    Histopathology; 2023 Feb; 82(3):385-392. PubMed ID: 36008876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas.
    Hiroshima K; Wu D; Koh E; Sekine Y; Ozaki D; Yusa T; Nakazawa T; Tsuji S; Miyagi Y; Walts AE; Marchevsky AM; Husain AN; Imai K
    Pathol Int; 2021 Sep; 71(9):604-613. PubMed ID: 34240508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4.
    Naso JR; Churg A
    Hum Pathol; 2020 Jun; 100():10-14. PubMed ID: 32333920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
    van Pel DM; Cheung S; Ionescu DN; Churg A
    Hum Pathol; 2023 Nov; 141():64-68. PubMed ID: 37776956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
    Tsuji S; Washimi K; Kageyama T; Yamashita M; Yoshihara M; Matsuura R; Yokose T; Kameda Y; Hayashi H; Morohoshi T; Tsuura Y; Yusa T; Sato T; Togayachi A; Narimatsu H; Nagasaki T; Nakamoto K; Moriwaki Y; Misawa H; Hiroshima K; Miyagi Y; Imai K
    Sci Rep; 2017 Mar; 7():45768. PubMed ID: 28361969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma.
    Naso JR; Cheung S; Ionescu DN; Churg A
    Am J Surg Pathol; 2021 Sep; 45(9):1245-1251. PubMed ID: 33782226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM; Cathro HP; Wick MR; Mills SE
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
    Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
    Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1.
    Matsuura R; Kaji H; Tomioka A; Sato T; Narimatsu H; Moriwaki Y; Misawa H; Imai K; Tsuji S
    Sci Rep; 2018 Sep; 8(1):14251. PubMed ID: 30250045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
    Ordóñez NG; Sahin AA
    Hum Pathol; 2014 Jul; 45(7):1529-40. PubMed ID: 24816068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
    Ordóñez NG
    Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ; Kushitani K; Kai Y; Suzuki R; Miyata Y; Okada M; Takeshima Y
    Mod Pathol; 2018 May; 31(5):809-815. PubMed ID: 29327712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
    Hinterberger M; Reineke T; Storz M; Weder W; Vogt P; Moch H
    Mod Pathol; 2007 Feb; 20(2):248-55. PubMed ID: 17361207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical diagnosis of epithelioid mesothelioma: an update.
    Ordóñez NG
    Arch Pathol Lab Med; 2005 Nov; 129(11):1407-14. PubMed ID: 16253021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
    Mawas AS; Amatya VJ; Kushitani K; Kai Y; Miyata Y; Okada M; Takeshima Y
    Sci Rep; 2018 Jan; 8(1):134. PubMed ID: 29317712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
    Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
    Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia.
    Chapel DB; Hirsch MS
    Am J Surg Pathol; 2022 Feb; 46(2):213-219. PubMed ID: 34411029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.